This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Insitro, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Adam Joseph Riesselman: Innovator in Microscopy Image Analysis
Introduction
Adam Joseph Riesselman is a notable inventor based in Brisbane, CA (US). He has made significant contributions to the field of microscopy image analysis, particularly in the context of disease modeling. His innovative work focuses on developing machine learning models that can effectively distinguish between healthy and diseased samples.
Latest Patents
Riesselman holds a patent for "Microscopy image analyses for disease modeling." This patent encompasses systems and non-transitory computer-readable media designed for analyzing microscopy images. The technology captures images from cells exhibiting various exposure response phenotypes (ERPs) and utilizes them to train machine learning models. The trained models are capable of differentiating between microscopy images from healthy and diseased samples, showcasing the potential for advancements in medical diagnostics.
Career Highlights
Currently, Adam Joseph Riesselman is employed at Insitro, Inc., a company that focuses on leveraging machine learning and data science to accelerate drug discovery. His role at Insitro allows him to apply his expertise in microscopy and machine learning to real-world challenges in healthcare.
Collaborations
Some of his notable coworkers include Daphne Koller and Ajamete Kaykas, who are also recognized for their contributions to the fields of machine learning and biotechnology.
Conclusion
Adam Joseph Riesselman's work in microscopy image analysis represents a significant advancement in the intersection of technology and healthcare. His innovative approach to developing machine learning models for disease modeling has the potential to enhance diagnostic capabilities and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile